September 18, 2015
Luitpold Pharmaceuticals Inc. is entitled to damages on claims that Swiss chemical and pharmaceutical conglomerate Ed. Geistlich Soehne AG breached licensing agreements by advertising its dental products in the U.S., a New York federal judge ruled Thursday.
1 other articles on this case. View all »